ACE2 and COVID-19: In addition, despite hypoxic upregulation of ACE2 and TMPRSS2 in HLMVECs, we did not observe any enhancing effect of hypoxia on SARS-CoV-2 infection, the condition that could prime lung EC activation state in COVID-19.